Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
Abstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary i...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-08-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13613-021-00917-2 |
id |
doaj-6e5e130ed1ff40ae95451b39246bbef6 |
---|---|
record_format |
Article |
spelling |
doaj-6e5e130ed1ff40ae95451b39246bbef62021-08-29T11:04:06ZengSpringerOpenAnnals of Intensive Care2110-58202021-08-011111810.1186/s13613-021-00917-2Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU surveyChristian Lanckohr0Christian Boeing1Jan J. De Waele2Dylan W. de Lange3Jeroen Schouten4Menno Prins5Maarten Nijsten6Pedro Povoa7Andrew Conway Morris8Hendrik Bracht9Antibiotic Stewardship Team, Department of Hygiene, University Hospital MünsterAntibiotic Stewardship Team, Department of Hygiene, University Hospital MünsterDepartment of Critical Care Medicine, Ghent University HospitalDepartment of Intensive Care Medicine, Universitair Medisch Centrum, University UtrechtDepartment of Intensive Care, Radboud UMCDept. Biomedical Engineering, Eindhoven University of TechnologyDepartment of Intensive Care Medicine, University of GroningenPolyvalent Intensive Care Unit, Hospital de São Francisco XavierDivision of Anaesthesia, University of CambridgeClinic for Anesthesiology, University Hospital UlmAbstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary insights into dissemination and structure of AMS programs and TDM practices in intensive care units. Methods This study involved online survey of members of ESICM and six national professional intensive care societies. Results Data of 812 respondents from mostly European high- and middle-income countries were available for analysis. 63% had AMS rounds available in their ICU, where 78% performed rounds weekly or more often. While 82% had local guidelines for treatment of infections, only 70% had cumulative antimicrobial susceptibility reports and 56% monitored the quantity of antimicrobials administered. A restriction of antimicrobials was reported by 62%. TDM of antimicrobial agents was used in 61% of ICUs, mostly glycopeptides (89%), aminoglycosides (77%), carbapenems (32%), penicillins (30%), azole antifungals (27%), cephalosporins (17%), and linezolid (16%). 76% of respondents used prolonged/continuous infusion of antimicrobials. The availability of an AMS had a significant association with the use of TDM. Conclusions Many respondents of the survey have AMS in their ICUs. TDM of antimicrobials and optimized administration of antibiotics are broadly used among respondents. The availability of antimicrobial susceptibility reports and a surveillance of antimicrobial use should be actively sought by intensivists where unavailable. Results of this survey may inform further research and educational activities.https://doi.org/10.1186/s13613-021-00917-2Antimicrobial stewardshipTherapeutic drug monitoringCritical careMultiresistant bacteriaAntibiotic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christian Lanckohr Christian Boeing Jan J. De Waele Dylan W. de Lange Jeroen Schouten Menno Prins Maarten Nijsten Pedro Povoa Andrew Conway Morris Hendrik Bracht |
spellingShingle |
Christian Lanckohr Christian Boeing Jan J. De Waele Dylan W. de Lange Jeroen Schouten Menno Prins Maarten Nijsten Pedro Povoa Andrew Conway Morris Hendrik Bracht Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey Annals of Intensive Care Antimicrobial stewardship Therapeutic drug monitoring Critical care Multiresistant bacteria Antibiotic |
author_facet |
Christian Lanckohr Christian Boeing Jan J. De Waele Dylan W. de Lange Jeroen Schouten Menno Prins Maarten Nijsten Pedro Povoa Andrew Conway Morris Hendrik Bracht |
author_sort |
Christian Lanckohr |
title |
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey |
title_short |
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey |
title_full |
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey |
title_fullStr |
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey |
title_full_unstemmed |
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey |
title_sort |
antimicrobial stewardship, therapeutic drug monitoring and infection management in the icu: results from the international a- teamicu survey |
publisher |
SpringerOpen |
series |
Annals of Intensive Care |
issn |
2110-5820 |
publishDate |
2021-08-01 |
description |
Abstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary insights into dissemination and structure of AMS programs and TDM practices in intensive care units. Methods This study involved online survey of members of ESICM and six national professional intensive care societies. Results Data of 812 respondents from mostly European high- and middle-income countries were available for analysis. 63% had AMS rounds available in their ICU, where 78% performed rounds weekly or more often. While 82% had local guidelines for treatment of infections, only 70% had cumulative antimicrobial susceptibility reports and 56% monitored the quantity of antimicrobials administered. A restriction of antimicrobials was reported by 62%. TDM of antimicrobial agents was used in 61% of ICUs, mostly glycopeptides (89%), aminoglycosides (77%), carbapenems (32%), penicillins (30%), azole antifungals (27%), cephalosporins (17%), and linezolid (16%). 76% of respondents used prolonged/continuous infusion of antimicrobials. The availability of an AMS had a significant association with the use of TDM. Conclusions Many respondents of the survey have AMS in their ICUs. TDM of antimicrobials and optimized administration of antibiotics are broadly used among respondents. The availability of antimicrobial susceptibility reports and a surveillance of antimicrobial use should be actively sought by intensivists where unavailable. Results of this survey may inform further research and educational activities. |
topic |
Antimicrobial stewardship Therapeutic drug monitoring Critical care Multiresistant bacteria Antibiotic |
url |
https://doi.org/10.1186/s13613-021-00917-2 |
work_keys_str_mv |
AT christianlanckohr antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT christianboeing antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT janjdewaele antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT dylanwdelange antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT jeroenschouten antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT mennoprins antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT maartennijsten antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT pedropovoa antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT andrewconwaymorris antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey AT hendrikbracht antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey |
_version_ |
1721187153027792896 |